CoChat

Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease

Open access
Guo, Xue, Huang, Chen, Xu, Jing, Xu, Haoming, Liu, Le, Zhao, Hailan, Wang, Jiaqi, Huang, Wenqi, Peng, Wu, Chen, Ye, Nie, Yuqiang, Zhou, Yongjian, Zhou, Youlian · 2022 · Frontiers in Nutrition
Cited by 165

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's disease (CD), is characterized by relapse and remission alternately. It remains a great challenge to diagnose and assess disease activity during IBD due to the lack of specific markers. While traditional biomarkers from plasma and stool, such as C-reactive protein (CRP), fecal calprotectin (FC), and S100A12, can be used to measure inflammation, they are not specific to IBD and difficult to determine an effective cut-off value. There is consensus that gut microbiota is crucial for intestinal dysbiosis is closely associated with IBD etiopathology and pathogenesis. Multiple studies have documented differences in the composition of gut microbiota between patients with IBD and healthy individuals, particularly regarding microbial diversity and relative abundance of specific bacteria. Patients with IBD have higher levels of Proteobacteria and lower amounts of Bacteroides, Eubacterium, and Faecalibacterium than healthy individuals. This review summarizes the pros and cons of using traditional and microbiota biomarkers to assess disease severity and treatment outcomes and addresses the possibility of using microbiota-focused interventions during IBD treatment. Understanding the role of microbial biomarkers in the assessment of disease activity and treatment outcomes has the potential to change clinical practice and lead to the development of more personalized therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnut.2021.818902

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 165

Metadata

Authors
Guo, X., Huang, C., Xu, J., Xu, H., Liu, L., Zhao, H., Wang, J., Huang, W., Peng, W., Chen, Y., Nie, Y., Zhou, Y., & Zhou, Y.
Venue
Frontiers in Nutrition
Published
2022-01-21
Volume
8
Pages
818902-818902
ISSN
2296-861X (ISSN-L)
OpenAlex
W4207077299
Cited by
165
References
26
FWCI
10.08
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease. https://app.cochat.ai/papers/10.3389/fnut.2021.818902
The paper
Guo, X., Huang, C., Xu, J., Xu, H., Liu, L., Zhao, H., Wang, J., Huang, W., Peng, W., Chen, Y., Nie, Y., Zhou, Y., & Zhou, Y. (2022). Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2021.818902

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.